Below are the latest News Releases for Clearmind Medicine Inc.
Clearmind Medicine Commences Trading On The Frankfurt Stock Exchange
Mark Haden, Psychedelic Medicine Expert, Joins Clearmind Medicine’s Advisory Board
A letter to shareholders from its Chief Executive Officer Dr. Adi Zuloff-Shani.
Clearmind Medicine Inc. Retains Edge Communications Group for Investor Relations and Announces Granting of Stock Options
Clearmind Medicine Inc. Announces Closing of Previously Announced Private Placements for Aggregate Gross Proceeds of CAD$6.225...
Clearmind Medicine Inc. Announces Increase to Previously Announced Non-Brokered Private Placement
Clearmind Medicine Inc. Announces Non-Brokered Private Placement and Granting of Stock Options
Cyntar Ventures Inc. Completes Change of Business Listing as it Shifts Focus to Psychoactive Pharmaceuticals for Underserved...
Clearmind Medicine Inc.
101 – 1220 W 6 Ave
Vancouver, BC V6H1A5
Telephone: (604) 260 1566
© Clearmind Medicines Inc.